Gail Entner Sonenshein, PhD, a professor in the department of biochemistry at Boston University School of Medicine, and director of the School’s Program in Research on Women’s Health, has been awarded the distinction of AAAS Fellow. Election as a Fellow is an honor bestowed upon AAAS members by their peers…
No Comments »
Filed under: Women's Health
Pandemic H1N1 influenza behaved much like seasonal and previous pandemic flu viruses in an early, isolated outbreak at a New York City high school, researchers found.
No Comments »
Filed under: General Health News
A study of household transmission of the H1N1 pandemic flu has confirmed that children 18 and younger are more at risk than young adults and seniors.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has warned patients, especially those using the internet to purchase medication, of a scam committed by individuals posing as agency and other law enforcement officials.
No Comments »
Filed under: General Health News
A New Hampshire woman has developed what may be the nation’s first case of gastrointestinal anthrax, with animal hides on imported drums suspected as the source.
No Comments »
Filed under: General Health News
Santarus, Inc., a specialty biopharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) requesting approval to begin a Phase III clinical program evaluating rifamycin SV MMX® in patients with travelers’ diarrhea.
No Comments »
Filed under: Pharmacy News
Pfizer Inc. announced today the discontinuation of A4021016 (also known as ADVIGO 1016), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) as first-line treatment in patients with advanced non-adenocarcinoma non-small cell lung cancer (NSCLC) due to the study meeting predefined boundaries for early termination.
No Comments »
Filed under: Pharmacy News
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced Merck and Co., Inc.’s decision (through an affiliate) to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena. Merck also informed Arena that the company will not continue the collaboration…
No Comments »
Filed under: Pharmacy News
Sinovac Biotech Ltd. ( SVA), a leading provider of biopharmaceutical products in China, announced that it has filed the application with China’s State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD)…
No Comments »
Filed under: Pharmacy News
Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant regions of ricin A chain, the antigenic component of RiVax((TM))…
No Comments »
Filed under: Pharmacy News
